161 related articles for article (PubMed ID: 37052737)
21. High dose rate brachytherapy for the local control of endobronchial carcinoma following external irradiation.
Hernandez P; Gursahaney A; Roman T; Schwartzman K; Donath D; Cosio MG; Levy RD
Thorax; 1996 Apr; 51(4):354-8. PubMed ID: 8733484
[TBL] [Abstract][Full Text] [Related]
22. High-dose-rate brachytherapy in symptom palliation due to malignant endobronchial obstruction: a quantitative assessment.
de Aquino Gorayeb MM; Gregório MG; de Oliveira EQ; Aisen S; Carvalho Hde A
Brachytherapy; 2013; 12(5):471-8. PubMed ID: 23541114
[TBL] [Abstract][Full Text] [Related]
23. Palliative endobronchial brachytherapy for non-small cell lung cancer.
Reveiz L; Rueda JR; Cardona AF
Cochrane Database Syst Rev; 2012 Dec; 12():CD004284. PubMed ID: 23235606
[TBL] [Abstract][Full Text] [Related]
24. Primary radiotherapy with endobronchial high-dose-rate brachytherapy boost for inoperable lung cancer: long-term results.
Rochet N; Hauswald H; Stoiber EM; Hensley FW; Becker HD; Debus J; Lindel K
Tumori; 2013; 99(2):183-90. PubMed ID: 23748812
[TBL] [Abstract][Full Text] [Related]
25. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
[TBL] [Abstract][Full Text] [Related]
26. Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?
Langendijk JA; Tjwa MK; de Jong JM; ten Velde GP; Wouters EF
Radiother Oncol; 1998 Nov; 49(2):175-83. PubMed ID: 10052884
[TBL] [Abstract][Full Text] [Related]
27. Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma.
Ofiara L; Roman T; Schwartzman K; Levy RD
Chest; 1997 Oct; 112(4):946-53. PubMed ID: 9377957
[TBL] [Abstract][Full Text] [Related]
28. High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.
Celebioglu B; Gurkan OU; Erdogan S; Savas I; Köse K; Kurtman C; Gonullu U
Jpn J Clin Oncol; 2002 Nov; 32(11):443-8. PubMed ID: 12499415
[TBL] [Abstract][Full Text] [Related]
29. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer.
Anacak Y; Mogulkoc N; Ozkok S; Goksel T; Haydaroglu A; Bayindir U
Lung Cancer; 2001 Nov; 34(2):253-9. PubMed ID: 11679184
[TBL] [Abstract][Full Text] [Related]
30. High dose rate intraluminal brachytherapy in the treatment of malignant airway obstructions.
Petera J; Spásová I; Neumanová R; Skricková J; Salajka F; Hrazdírová A; Kaplanová J; Coupková H; Coupek P; Kucera M
Neoplasma; 2001; 48(2):148-53. PubMed ID: 11478697
[TBL] [Abstract][Full Text] [Related]
31. Endobronchial brachytherapy in the treatment of malignant lung tumours.
Escobar-Sacristán JA; Granda-Orive JI; Gutiérrez Jiménez T; Delgado JM; Rodero Baños A; Saez Valls R
Eur Respir J; 2004 Sep; 24(3):348-52. PubMed ID: 15358689
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors for late toxicity after endobronchial brachytherapy: a multivariate analysis.
Hennequin C; Tredaniel J; Chevret S; Durdux C; Dray M; Manoux D; Perret M; Bonnaud G; Homasson JP; Chotin G; Hirsch A; Maylin C
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):21-7. PubMed ID: 9747815
[TBL] [Abstract][Full Text] [Related]
33. [High-dose rate endobronchial brachytherapy: results and complications in 189 patients].
Taulelle M; Chauvet B; Vincent P; Félix-Faure C; Bucciarelli B; Garcia R; Reboul F
Bull Cancer Radiother; 1996; 83(3):127-34. PubMed ID: 8977562
[TBL] [Abstract][Full Text] [Related]
34. High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results.
Nori D; Allison R; Kaplan B; Samala E; Osian A; Karbowitz S
Chest; 1993 Oct; 104(4):1006-11. PubMed ID: 7691481
[TBL] [Abstract][Full Text] [Related]
35. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
36. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies.
Gustafson G; Vicini F; Freedman L; Johnston E; Edmundson G; Sherman S; Pursel S; Komic M; Chen P; Borrego JC
Cancer; 1995 May; 75(9):2345-50. PubMed ID: 7712446
[TBL] [Abstract][Full Text] [Related]
37. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study.
Langendijk H; de Jong J; Tjwa M; Muller M; ten Velde G; Aaronson N; Lamers R; Slotman B; Wouters M
Radiother Oncol; 2001 Mar; 58(3):257-68. PubMed ID: 11230886
[TBL] [Abstract][Full Text] [Related]
38. Second line palliative endobronchial radiotherapy with HDR Ir 192 in recurrent lung carcinoma.
Zorlu AF; Selek U; Emri S; Gurkaynak M; Akyol FH
Yonsei Med J; 2008 Aug; 49(4):620-4. PubMed ID: 18729305
[TBL] [Abstract][Full Text] [Related]
39. [The role of high dose rate (HDR) brachytherapy in advanced non-small cell lung cancer].
Makarewicz R
Pneumonol Alergol Pol; 2002; 70(5-6):265-77. PubMed ID: 12518625
[TBL] [Abstract][Full Text] [Related]
40. Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract.
Harms W; Schraube P; Becker H; Latz D; Herth F; Fritz P; Wannenmacher M
Strahlenther Onkol; 2000 Feb; 176(2):60-6. PubMed ID: 10697652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
